1. Addison I, Baggage J, Gandossini M, Souhami R. Assessment of host defense against infection during chemotherapy of Hodgkin's disease. Cancer Chemother Pharmacol 1978; 1:129–133.
2. Adler A, Stein JA, Ben-Efraim S. Immunocompetence, immuno-suppression, and human breast cancer, II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T). Cancer 1980; 45:2061–2073.
3. Adler A, Stein JA, Ben-Efraim S. Immunocompetence, immuno-suppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease. Cancer 1980; 45:2074–2083.
4. Ahmed K, Turk JL. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro. Cancer Immunol Immunother 1989; 28:87–92.
5. Alberola V, Gonzalez-Molina A, Trenor A, et al. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients. Allergol Immunopathol (Madr) 1985; 13:213–219.